An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy.

Saved in:
Bibliographic Details
Title: An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy.
Authors: Blaye C; Department of Medical Oncology, Institut Bergonié, Bordeaux, France; Univ. Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France., Darbo É; Univ. Bordeaux, INSERM U1218, ACTION Laboratory, Bordeaux, France., Debled M; Department of Medical Oncology, Institut Bergonié, Bordeaux, France., Brouste V; Departments of Clinical Research and Medical Information, Bordeaux, France., Vélasco V; Biopathology, Institut Bergonié, Bordeaux, France., Pinard C; Pathology Laboratory, University Hospital of Martinique, Fort de France., Larmonier N; Univ. Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France; Univ. Bordeaux, Bordeaux, France., Pellegrin I; Service d'Immunologie et Immunogénétique, University Hospital of Bordeaux, Bordeaux, France; Centre de Ressources Biologiques Plurithématique, University Hospital of Bordeaux, Bordeaux, France., Tarricone A; Service d'Immunologie et Immunogénétique, University Hospital of Bordeaux, Bordeaux, France., Arnedos M; Department of Medical Oncology, Institut Bergonié, Bordeaux, France., Commeny J; Department of Surgery, Institut Bergonié, Bordeaux, France., Bonnefoi H; Department of Medical Oncology, Institut Bergonié, Bordeaux, France; Univ. Bordeaux, INSERM U1218, ACTION Laboratory, Bordeaux, France; Univ. Bordeaux, Bordeaux, France., Larmonier C; Biopathology, Institut Bergonié, Bordeaux, France., MacGrogan G; Univ. Bordeaux, INSERM U1218, ACTION Laboratory, Bordeaux, France; Biopathology, Institut Bergonié, Bordeaux, France. Electronic address: g.macgrogan@bordeaux.unicancer.fr.
Source: ESMO open [ESMO Open] 2022 Aug; Vol. 7 (4), pp. 100502. Date of Electronic Publication: 2022 Jun 24.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2059-7029
DOI:10.1016/j.esmoop.2022.100502